Insightful discoveries
Our technologies analyse drug structures, pharmacological drug data, drug side effects and associated disease phenotypes to discover novel and hidden connections between targets, drugs and diseases.
Healx
Partnerships
Partner with us to develop the next rare disease therapy
Our drug hunters work in concert with our AI platform to discover and analyse drug-disease-target interactions at scale
Healx pipeline
In just five years, we’ve discovered and delivered several new treatments towards the clinic. We develop partnerships to license some of these treatments out and to license promising, clinic-ready treatments in.
Learn more
Rare disease discovery partnership
Partner with us to access our AI technology to discover novel rare disease treatments.
Combination drug discovery
Our AI platform discovers combinations that enhance the monotherapies developed by our partners and academic labs.
Licensing opportunities
To get therapies to patients quicker, we both in-licence and out-license safe clinic-ready and clinically validated assets.
Co-development partnerships
We work with our partners to combine their clinical development expertise with our technology and rare disease assets.
Our AI-powered biotech Our AI is made up of a unique combination of drug-matching, predictive technologies. They empower experts to make:
Better decisions
Rather than approaching the biology of a rare disease with a predetermined target in mind, our technologies use gene expression data to connect drugs and diseases without prior assumptions.
A greater impact
Our technologies present the connections they discover in the form of a knowledge graph. The results are also prioritised, which helps our pharmacologists speed up the interpretation and validation process.
